Helen Torley Halozyme Therapeutics, Inc. (HALO) insider trading activity
Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 733,719 shares of HALO, which is worth approximately $43.4 Million. The most recent transaction as insider was on Jan 19, 2023, when has been sold 10,000 shares (Common Stock) at a price of $52.41 per share, resulting in proceeds of $524,099. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
734K
10.05%
3M change
8.42%
12M change
Total Value Held
$43.4 Million
Helen Torley Transaction History
Also insider at
HT
Helen Torley
PRESIDENT AND CEO
Secaucus, NJ